Literature DB >> 18694837

Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.

Jonghan Shin1, Sang-Yoon Lee, So-Hee Kim, Young-Bo Kim, Seong-Jin Cho.   

Abstract

Recently developed positron emission tomography (PET) tracers, such as PIB and FDDNP, help to visualize amyloid plaques and neurofibrillary tangles in living subjects. FDDNP binds to both amyloid plaques and tangles, whereas PIB selectively labels amyloid plaques. Therefore, it will be interesting to see a direct comparison of the regional binding of the two radiotracers for plaques (PIB) and plaques and tangles (FDDNP) using multitracer PET imaging for both PIB and FDDNP in the same subjects with and without Alzheimer's disease. Here we report that multitracer PET images of PIB and FDDNP in the same Alzheimer subjects show negligible PIB but strong FDDNP binding in the medial temporal cortex (hippocampus, amygdala, and parahippocampal gyrus), whereas there are significant quantities of both PIB and FDDNP binding in neocortical areas. These results suggest that tangles rather than amyloid plaques are the dominant pathology in the medial temporal cortex of living Alzheimer patients. In nondemented elderly normal subjects, PIB binding shows a significant increase in the posterior cingulate cortex compared with other brain regions, whereas in the same normal subjects we found significant FDDNP binding in the medial temporal cortex. Interestingly, the medial temporal FDDNP uptake values in normal elderly subjects were inversely correlated with long delay recall scores in the California Verbal Learning Test, a measure of episodic memory performance. We conclude that multitracer PET imaging of amyloid plaques and tangles using FDDNP and PIB in both nondemented and demented subjects provides important insight into these complicated pathological processes in living subjects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18694837     DOI: 10.1016/j.neuroimage.2008.07.022

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  42 in total

Review 1.  Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia.

Authors:  William E Klunk
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

2.  Prediction of cognitive decline based on hemispheric cortical surface maps of FDDNP PET.

Authors:  Hillary D Protas; Vladimir Kepe; Kiralee M Hayashi; Andrea D Klunder; Meredith N Braskie; Linda Ercoli; Prabha Siddarth; Susan Y Bookheimer; Paul M Thompson; Gary W Small; Jorge R Barrio; Sung-Cheng Huang
Journal:  Neuroimage       Date:  2012-02-28       Impact factor: 6.556

3.  Brain metabolic correlates of decision making in amnestic mild cognitive impairment.

Authors:  H Randall Griffith; Ozioma C Okonkwo; Jan A den Hollander; Katherine Belue; Jacqueline Copeland; Lindy E Harrell; John C Brockington; David G Clark; Daniel C Marson
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2010-04-06

4.  Protein binding in patients with late-life depression.

Authors:  Anand Kumar; Vladimir Kepe; Jorge R Barrio; Prabha Siddarth; Vicki Manoukian; Virginia Elderkin-Thompson; Gary W Small
Journal:  Arch Gen Psychiatry       Date:  2011-11

Review 5.  Clinical applications of PET amyloid imaging: an update.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-07       Impact factor: 9.236

6.  Knowing the natural course of biomarkers in AD: longitudinal MRI, CSF and PET data.

Authors:  W M Van Der Flier; P Scheltens
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

Review 7.  Modulation and detection of tau aggregation with small-molecule ligands.

Authors:  Edward Chang; Nicolette S Honson; Bhaswati Bandyopadhyay; Kristen E Funk; Jordan R Jensen; Sohee Kim; Swati Naphade; Jeff Kuret
Journal:  Curr Alzheimer Res       Date:  2009-10       Impact factor: 3.498

Review 8.  [Diagnosis without therapy: early diagnosis of Alzheimer's disease in the stage of mild cognitive impairment].

Authors:  H-J Gertz; A Kurz
Journal:  Nervenarzt       Date:  2011-09       Impact factor: 1.214

9.  Movement correction method for human brain PET images: application to quantitative analysis of dynamic 18F-FDDNP scans.

Authors:  Mirwais Wardak; Koon-Pong Wong; Weber Shao; Magnus Dahlbom; Vladimir Kepe; Nagichettiar Satyamurthy; Gary W Small; Jorge R Barrio; Sung-Cheng Huang
Journal:  J Nucl Med       Date:  2010-01-15       Impact factor: 10.057

Review 10.  Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.

Authors:  Ann D Cohen; Gil D Rabinovici; Chester A Mathis; William J Jagust; William E Klunk; Milos D Ikonomovic
Journal:  Adv Pharmacol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.